Authors


Shameema Sikder, MD

Latest:

Ophthalmology sees AI-powered impact on cataract and diabetic eye disease

Shameema Sikder, MD; and T. Y. Alvin Liu, MD, highlight the technology’s role in bridging challenges and successes for clinical practice.


Lisa K. Feulner, MD, PhD

Latest:

Advances in cataract surgery show value in tools, tech for surgeons

Three cases demonstrate value of new tools, technology for surgeons.


George Spaeth, MD

Latest:

Glaucoma 45 years later: Much changed, much unchanged

Innovation, change has dominated the glaucoma specialty over the years.


Margaret Chang, MD

Latest:

Steps for implantation and refill of PDS with ranibizumab

Margaret Chang, MD, outlines the steps for the surgical procedure to implant and refill the Port Delivery System (PDS).


Kelly K. Nichols, OD, MPH, PhD, FAAO

Latest:

EyeCon 2024: Key takeaways for enhanced patient care from Day 1

Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.


John D. Sheppard, MD, MMSc, FACS

Latest:

Are your patients suffering in silence with dry eye disease?

By taking a proactive approach to treatment, ophthalmologists can identify the “silent sufferers.”


Ariana Levin, MD

Latest:

The Residency Report: Clinical insights from the iStent infinite trial

A conversation with David S. Friedman, MD, PhD, on treating uncontrolled open-angle glaucoma in patients with limited options


Sonia H. Yoo, MD

Latest:

EnVision Summit 2025: Sonia H. Yoo, MD, shares what to expect from the cataract and refractive session

Sonia H. Yoo, MD, a cornea, cataract, and refractive surgery specialist and a member of the planning committee for the EnVision Summit, highlights a session focused on the latest advancements in lens implant technologies, refractive procedures, and imaging innovations. The summit will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.


Aaron D. Dotson, MD

Latest:

BLOG: Being the change we want to see in ophthalmology

A recent study showed that only 6% of practicing ophthalmologists in the US identify as an underrepresented minority.


Savak Teymoorian, MD

Latest:

Ocular implants can be a gateway to better glaucoma care

Until new innovations began transforming the field a decade ago, ophthalmologists had a limited toolbox. This option allows ophthalmologists to provide positive outcomes for their patients.


Andrew Carey, MD

Latest:

NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy

Andrew G. Lee, MD, and Drew Carey, MD, discuss how baseline optical coherence tomography parameters can help ophthalmologists counsel patients and make more informed decisions after ethambutol-associated optic neuropathy.


Karl Csaky, MD, PhD

Latest:

Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD

Findings presented at the Heidelberg 2025 International SPECTRALIS Symposium — And Beyond (ISS) suggest detailed structural data could better inform therapeutic targeting and monitoring.


Gheorghe Necula, MD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.


Balwantray C. Chauhan, PhD,

Latest:

Balwantray C. Chauhan, PhD, explores in vivo functional imaging of single retinal ganglion cells with two-photon imaging

At the 2025 International SPECTRALIS Symposium—And Beyond (ISS), Chauhan discussed how two-photon microscopy enables precise, non-invasive monitoring of retinal ganglion cell function in living subjects.


Carlton Yuen, MD

Latest:

Depth-of-focus enhancement makes target easier to hit

Lens an option for complicated eyes, astigmatism, monovision candidates.


David Szanto, BA

Latest:

Artificial intelligence enhances detection of neuro-ophthalmic disorders

Deep learning discerns IIH, NAION, and normal eyes using single fundus image.


Glenn Yiu, MD, PhD

Latest:

Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3

Ixo-vec shows sustained efficacy and reduces injection burden through 4 years in clinical trials


Bret L. Fisher, MD

Latest:

Comparable conscious sedation methods address individual patient needs

Sublingual troche sedation represents attractive anesthesia option for specific subset of patients with cataracts.



Ruth Hogg, PhD

Latest:

Ruth Hogg, PhD, on what retinal imaging can tell clinicians about the brain and body

With detailed imaging and cognitive data, the Northern Ireland Cohort for the Longitudinal Study of Aging highlights the potential of integrating eye scans into broader health research.


Noha Ekdawi, MD, FAAP

Latest:

Experience with Soft Contact Lenses for Pediatric Myopia

Dr Noha Ekdawi shares her experience using soft contact lenses to combat myopia progression and emphasizes the importance of proactive treatment in managing myopia effectively.


David P. Piñero, PhD

Latest:

Link between neurodevelopmental disorders, visual problems studied

Investigators find that youth show altered ocular movements, reduced amplitude of accommodation.


Michael Mbagwu, MD

Latest:

Intracanalicular corticosteroid insert safe for postsurgical inflammation, pain

Study demonstrates power of IRIS Registry for evaluation of safety, efficacy


Abigail T. Fahim, MD, PhD

Latest:

The Residency Report: Study provides new insights into USH2A target end points

Researchers evaluate key measures for tracking disease progression in Usher syndrome type 2–related retinal degeneration


Lisa Nijm, MD

Latest:

ASCRS 2025: New research findings highlight the surprising impact of hyperosmolarity

Lisa Nijm, MD, says preoperative osmolarity testing can help clinicians manage patient expectations and improve surgical results.


Ying Han, MD, PhD

Latest:

Managing the complexities of glaucoma care with Ying Han, MD, PhD

Ying Han, MD, PhD discusses glaucoma management strategies, including transitioning care between ophthalmologists and optometrists, improving diagnosis, and the hope for future glaucoma developments.


Rebekah Bernard, MD

Latest:

Strategies for coping with physician depression during COVID-19

Medical practitioners face emotional burden, other hurdles from pandemic


Mark Barakat, MD

Latest:

ARVO 2025: Shortened, maintained, or extended dosing intervals through 96 weeks in PHOTON

At ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg versus 2 mg during the matched dosing phase, and outcomes of shortened, maintained, or extended dosing intervals


J. Peter Campbell, MD

Latest:

Partners collaborate on integration of AI-supported ROP telemedicine globally

Siloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.


Jai G. Parekh, MD, MBA, FAAO

Latest:

50 years of ophthalmology: What changed the game (Part 2)

Ophthalmologists discuss the most impactful advancements reshaping patient care over five decades.

© 2025 MJH Life Sciences

All rights reserved.